US 10558394
Injectable flowable composition comprising buprenorphine
granted A61KA61K31/00A61K31/4748
Quick answer
US patent 10558394 (Injectable flowable composition comprising buprenorphine) held by Indivior UK Limited expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/00, A61K31/4748, A61K31/485, A61K47/22